DEEPVESSEL® FFR
FFR CT Analysis for Coronary Artery Functional Assessment
FDA Cleared, CE Marked, and NMPA Approved.
Select:
DEEPVESSEL FFR (DVFFR) is a software medical device that utilizes deep learning technology to assess the physiological function of coronary arteries non-invasively through coronary computed tomography angiography. By processing coronary CTA images and creating a 3D model of the artery tree, it calculates DVFFR values, generating a PDF report for physicians. The system aims to aid in the functional evaluation of coronary artery disease, employing Keya Medical's proprietary DeepVessel and DeepFFR techniques, which offer high performance, fast processing, and precise non-invasive FFR analysis.
Advantages
Multi-national multi-center clinical validation study ADAPT1
- DVFFR analysis was conducted on a total of 269 patients with 358 target vessels from 10 clinical sites (5 from US and 5 from EU)
- Primary endpoint: per-vessel sensitivity and specificity of DVFFR to detect ischemic condition comparing with invasive FFR measurement
- Study demonstrated that DVFFR yielded good diagnostic performance and met pre-specified criteria for study success
DEEPVESSEL® FFR
FFR CT Analysis for Coronary Artery Functional Assessment
FDA Cleared, CE Marked, and NMPA Approved.
Improving Diagnosis & Treatment of Patients with Coronary Artery Disease with FFR CT
DEEPVESSEL FFR (DVFFR) is a software medical device that utilizes deep learning technology to assess the physiological function of coronary arteries non-invasively through coronary computed tomography angiography. By processing coronary CTA images and creating a 3D model of the artery tree, it calculates DVFFR values, generating a PDF report for physicians. The system aims to aid in the functional evaluation of coronary artery disease, employing Keya Medical's proprietary DeepVessel and DeepFFR techniques, which offer high performance, fast processing, and precise non-invasive FFR analysis.
Advantages
Multi-national multi-center clinical validation study ADAPT1
- DVFFR analysis was conducted on a total of 269 patients with 358 target vessels from 10 clinical sites (5 from US and 5 from EU)
- Primary endpoint: per-vessel sensitivity and specificity of DVFFR to detect ischemic condition comparing with invasive FFR measurement
- Study demonstrated that DVFFR yielded good diagnostic performance and met pre-specified criteria for study success
